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Malaria is caused by one or more of four intracellular
parasitic protozoa of the genus Plasmodium (P. falci-
parum, P. vivax, P. malariae, P. ovale), and is transmitted
by the infected female Anopheles mosquito during
blood meals. It is a life-threatening disease that causes
major international medical concern. Of the 300 to 500
million cases reported annually, 1.5 to 3.5 million
result in death [1]. Africa, Southeast Asia (excluding
Taiwan and Singapore), and Central and South
America are major epidemic areas of malaria. The
most affected area, with 90% of cases resulting in
deaths every year, is rural sub-Saharan Africa [2].
Despite 50 years of control efforts, malaria remains
one of the main global public health issues [3].
Before World War II, Taiwan was considered a
hyperendemic area for malaria. The malaria eradication
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Malaria, a major public health problem worldwide, is a predominant infectious disease in most
tropical and subtropical countries. Before 1965, Taiwan was a hyperendemic area, but most cases
are now imported. We present our experience of dealing with various malaria infections. Charts
of malaria patients visiting university hospitals in southern Taiwan between January 1991 and
June 2002 were available for review. All diagnoses were made by positive blood smear and
detailed history that included countries visited, paroxysm of symptoms, and medical treatment.
Seventeen patients, 6 women and 11 men (mean age, 32.3 ± 11.8 years), were enrolled. Six were
infected with Plasmodium falciparum, eight with Plasmodium vivax, two with a combination of
P. falciparum and P. vivax, and one with an unidentified infection. All Taiwanese patients infected
with P. falciparum (n = 5) contracted the disease in Africa or Indonesia. All Taiwanese patients
infected with P. vivax (n = 4) contracted the disease in Southeast Asia or Oceania. Fever and
chills were the leading symptoms of malaria. P. falciparum infection was treated with quinine
and doxycycline/tetracycline, with the addition of artesunate for cerebral malaria. P. vivax
infection was treated with chloroquine and primaquine. Maintaining a high degree of suspicion
in patients with a history of travel to malaria-endemic areas is the major cornerstone of malaria
diagnosis. Erroneous diagnosis and improper treatment leads to greater morbidity and even
mortality.
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program in Taiwan, from 1947 to 1965, was successful
[4]. By November 1965, the World Health Organiza-
tion certified Taiwan as a malaria-eradicated area.
From 1965, the Taiwan Malaria Research Institute
(TAMRI) played an important role in the consolida-
tion phases of malaria control. By 1969, TAMRI be-
came the Provincial Institute of Infectious Diseases,
starting a priority program that included the epide-
miologic investigation of international travelers, ento-
mologic monitoring of Anopheles minimus, and super-
vision and guidance for an adequate case detection
program [4]. In July 1999, the Center for Disease Con-
trol (CDC) was established to assess the development
of infectious patterns, integrate preventive resources,
and build a complete epidemic control system. The
task of the CDC today is the surveillance and treat-
ment of various epidemic situations in Taiwan, in-
cluding malaria. The aim of this collection of malaria
cases is to arouse clinical vigilance by presenting our
recommendations on malaria treatment and risk.
MATERIALS AND METHODS
Charts of all malaria patients who visited the
emergency department of the National Cheng Kung
University Hospital between January 1991 and June
2002 were reviewed. Patients’ clinical symptoms and
chief complaints were assessed, and Giemsa- or Wright-
stained thick and thin blood smears were examined. If
any of the four malaria species were observed at any
level of parasitemia, a positive diagnosis of malaria
infection was made. Suspected specimens were sent to
the local CDC health department for further docu-
mentation. The cases of patients who had contracted
malaria were reviewed in detail regarding nationality,
country of travel, paroxysm of symptoms, and
treatment course.
RESULTS
A total of 17 patients, 6 females and 11 males, with a
mean age of 32.3 ±  11.8 years, who had contracted
malaria were detected in our hospital during the
survey. Of these cases, 12 were Taiwanese, one was
Chinese, and four were of other nationalities (Table 1).
All reported cases, including two transplant recipients,
were of imported malaria (Table 2). Six patients (5
Taiwanese, 35%) had contracted P. falciparum in Africa
or Southeast Asia. Eight patients (4 Taiwanese, 47%)
had contracted P. vivax, two while in Papua New
Guinea and two after kidney transplantations in India.
A further two (12%) Taiwanese patients were infected
with a combination of P. falciparum and P. vivax, one
from Southeast Asia and the other from Mainland
China, and one Taiwanese patient had an unidentified
infection from Africa.
Major clinical manifestations were fever (17/17)
and chills (13/17), and the symptoms and signs by
priority were as follows: anemia, abnormal liver
function test, hepatomegaly/splenomegaly, hema-
turia, central nervous system (CNS) involvement
(cerebral malaria), and hypoglycemia (Figure). No
fatalities were reported in any of these cases.
The treatment regimen varied according to the
infecting species. Originally, chloroquine was the first
line anti-malaria drug for treatment of all Plasmodium
species. However, recently, there has been widespread
resistance to chloroquine among P. falciparum [2]. We
gave both quinine and doxycycline/tetracycline to
five of our six cases infected with P. falciparum, and
one case was treated with these drugs in combination
with mefloquine. In addition, artesunate was used in
two cases with cerebral malaria. Since chloroquine is
considered safe during pregnancy [5], it was used in
all eight cases of P. vivax, including in two pregnant
women. The remaining six patients were treated with
a combination of chloroquine and primaquine. Many
months after the initial infection with P. vivax, cases
can be complicated by dormant intrahepatic parasites
that can actively infect erythrocytes. It is necessary to
eradicate these dormant organisms and prevent a re-
lapse by supplementary treatment with primaquine
[6].
DISCUSSION
From 1991 to 2002, 446 cases of malaria were found by
the case reporting system in Taiwan. Of these, 436
were classified as imported malaria, seven as secondary
infection originating from imported cases, and three
as relapses (Table 3). The 17 patients who visited the
emergency department of the National Cheng Kung
University Hospital between January 1991 and June
2002 had imported malaria; no indigenous cases were
found. Therefore, it appears that indigenous malaria
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Table 1. Details of malaria patients
Case Sex Age Nationality Date fell Incubation Hospitalization Species Complications Medications
(yr) ill (d) (d)
1 M 47 Taiwanese 2002/06/06 7 11 PF, PV Cerebral malaria, Primaquine,
hematuria, quinine,
abnormal LFT doxycycline,
artesunate
2 F 30 Taiwanese 2000/08/20 NA 5 Unidentified Abnormal LFT Mefloquine,
quinine,
doxycycline
3 M 37 Taiwanese 2000/05 4 10 PF Cerebral malaria, Quinine,
abnormal LFT, doxycycline,
anemia artesunate
 4* F 24 Chinese 1998/10/05 7 4 PV Abnormal LFT, Chloroquine
anemia,
hypoglycemia
5 M 28 Taiwanese 1998/01/21 14 11 PF, PV Hematuria, Chloroquine,
splenomegaly, primaquine,
abnormal LFT, quinine,
anemia doxycycline
6 F 54 Taiwanese 1997/08 7 6 PF Hematuria, Quinine,
splenomegaly, doxycycline
hemolysis/anemia
7 F 41 Taiwanese 1997/08/11 9 14 PF Hematuria, Quinine,
hepato-/splenomegaly, doxycycline
abnormal LFT,
hemolysis/anemia
8 M 37 English 1997/07/06 7 3 PF Hematuria, Quinine,
splenomegaly, doxycycline
abnormal LFT,
hemolysis/anemia
9 M 18 Thai 1997/06/08 4–5 5 PV Splenomegaly, Chloroquine,
abnormal LFT, primaquine
hemolysis/anemia
10 M 45 Taiwanese 1997/02 NA 3 PV NA Chloroquine,
primaquine
11 M 36 Taiwanese 1997/01 NA 3 PV Splenomegaly (±) Chloroquine,
primaquine
12 M 52 Taiwanese 1995/06/15 5–6 7 PF Hematuria, Quinine, TC
hepato-/splenomegaly,
abnormal LFT,
hemolysis/anemia
13 M 8 Indian 1995/05/04 7 7 PV Abnormal LFT, Chloroquine,
anemia primaquine
14 M 37 Taiwanese 1994/08 14 9 PF Hepato-/splenomegaly, Mefloquine,
anemia quinine, TC
 15† F 33 Taiwanese 1993/05 NA 14 PV Anemia Chloroquine,
primaquine
 16† M 26 Taiwanese 1993/05/13 NA 22 PV Hepato-/splenomegaly, Chloroquine,
anemia primaquine
 17* F 17 Sri Lankan 1991/06/22 NA 5 PV Anemia Chloroquine
*Pregnant; †renal transplantation. PF = P. falciparum; PV = P. vivax; LFT = liver function test; NA = not available; TC = tetracycline.
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has been effectively destroyed by the malaria eradica-
tion program in Taiwan. With the increasing numbers
of international travelers and the introduction of large
numbers of foreign workers, especially from South-
east Asian countries, greater vigilance regarding the
possibility of imported malaria is necessary.
P. vivax was more frequently detected in our cases
(47%) than the other three causative agents; about
two-thirds of patients (63%) had been infected in South-
east Asia. P. vivax is one of the three so-called benign
malarias (P. vivax, P. ovale, P. malaria) that cause a
relatively mild form of malaria, which usually has
fewer severe complications and is rarely fatal, even if
it is not diagnosed early. Six patients (35%) were
infected with P. falciparum, and all of these had a travel
history including Africa or Southeast Asia. P. falciparum,
Figure. Major clinical manifestations of imported malaria patients at National Cheng Kung University Hospital (1991–2002).
LFT = liver function test; CNS = central nervous system.
Table 2. Presumed countries of contraction of infection with Plasmodium species, shown as country (number of patients)
Africa Southeast Asia Mainland China Oceania
P. falciparum Zambia (1) Indonesia (2)
Nigeria (1) Malaysia (1)
Cameroon (1)
P. vivax Sri Lanka (1) Wuhan (1) Papua New
India (3) Guinea (2)
Burma (1)
Mixed Burma (1) Hainan (1)
Unidentified Nigeria (1)
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which causes so-called malignant malaria, progresses
rapidly, leading to lethal multisystem disorders, and
has a higher mortality rate. It is still the most prevalent
infection in tropical and subtropical countries and
accounts for most malaria-related deaths [2].
In children, the clinical features that indicate a
poor prognosis for malaria include age less than 1
year, hypoglycemia (< 40 mg/dL), convulsions (≥ 3
times in 24 hours), or severe anemia. In adults, CNS
involvement (coma, seizure), shock, acidosis (HCO3 <
15 mmol/L), acute renal failure, jaundice (total
bilirubin > 2.5 mg/dL), or pulmonary edema contribute
to a poor prognosis [7,8]. The early diagnosis of
P. falciparum is essential so that timely medical attention
can be offered. The complications of severe malaria
are often fatal and they are most common in individuals
with little or no background immunity, i.e. children in
tropical countries or travelers from temperate zones.
It is important, therefore, that physicians are aware of
the possibility of patients returning with malaria from
malaria-endemic areas.
Plasmodia enter circulating erythrocytes and feed
on the hemoglobin and other proteins within the cells.
The protozoa replicate inside the cells, inducing
erythrocyte cytolysis and causing the release of toxic
metabolic byproducts into the bloodstream. The host
then experiences flu-like symptoms such as chills,
headache, and myalgias. The plasmodia also suppress
hematopoiesis and increase clearance of erythrocytes
by the spleen, leading to anemia, jaundice, and
hepatosplenomegaly [1]. P. vivax lies dormant in the
liver of infected individuals, emerging at a later date.
In our study, 10 patients (including those with mixed
species, 59%) suffered from P. vivax. The most common
clinical symptoms were anemia, abnormal liver
function, and hepatosplenomegaly. The remaining
cases contracted P. falciparum, which leads to renal
failure or hematuria. It is also likely to cause severe
malaria with impaired cerebral function (cerebral
malaria), resulting either in coma or death, especially
when other organs become involved. Cerebral malaria
occurs in 0.5% to 1.0% of P. falciparum infections, with
mortality rates ranging from 10% to 40% [9,10]. Cerebral
malaria is due to the cytoadherence of infected
erythrocytes. When an erythrocyte becomes infected
with P. falciparum, it produces proteinaceous knobs
that bind the erythrocyte to endothelial cells. This
adherence causes erythrocytes to clump together in
the cerebral capillaries and venules, leading to a clinical
neurologic syndrome [11]. Only eight of our cases
(47%, including the mixed species infection) contracted
P. falciparum, and only two of these developed cerebral
Table 3. Statistical information on the malaria population in Taiwan from 1991 to 2002
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Number of cases 30 42 36 35 38 38 50 49 32 42 28 26
Imported 29 42 36 35 31 38 49 49 32 42 27 26
Relapsing 1 0 0 0 1 0 0 0 0 0 1 0
Secondary infection 0 0 0 0 6 0 1 0 0 0 0 0
P. falciparum 11 16 12 15 20 12 27 22 10 15 12 NA
P. vivax 18 24 23 20 17 23 20 27 20 24 13 NA
Mixed 0 1 0 0 1 1 1 0 0 0 2 NA
P. malariae 1 1 0 0 0 1 0 0 0 2 1 NA
P. ovale 0 0 1 0 0 1 2 0 2 1 0 NA
Africa NA 10 6 12 10 5 21 13 9 11 8 NA
Southeast Asia NA 26 26 17 17 26 22 29 21 29 17 NA
Oceania NA 2 0 0 0 2 4 4 1 1 0 NA
Mainland China NA 3 3 6 4 4 1 3 1 1 2 NA
Others NA 1 1 0 7 1 2 0 0 0 1 NA
NA = not available. (Data from A News Report of Epidemic Situation. Taipei: CDC, monthly reports from 1991 to 2002.)
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malaria,  giving a relatively low rate of CNS
involvement. In summary, although both P. falciparum
and P. vivax can cause severe anemia, only P. falciparum
can cause complications such as cerebral malaria and
hematuria.
Pregnancy enhances susceptibility to malaria, and
is associated with an increased risk of anemia [12].
Both of the pregnant women in this case series had this
complication. Moreover, hypoglycemia is very com-
mon in pregnant patients with malaria [13]. The
parasites derive their energy solely from glucose, and
they metabolize it 70 times faster than the erythrocytes
they inhabit, thereby causing hypoglycemia [2].
Nevertheless,  only one pregnant patient had
hypoglycemic symptoms. Both pregnant patients had
contracted P. vivax. As there is no P. vivax resistance to
chloroquine, unlike P. falciparum, the preferred agent
for therapy was chloroquine [14]. For chloroquine-
resistant malaria, quinine combined with clindamycin
is the treatment of choice during pregnancy. Blood
sugar should be monitored frequently because
hypoglycemia may be exacerbated by quinine therapy
[5].
Two cases in this report had undergone renal
transplantation in India (an area of endemic malaria),
which was the most likely cause of infection. Despite
the fact that malaria causes a temporary rise in serum
creatinine levels [15], the two patients had normal
renal function. Malaria should be suspected in all
patients who have undergone renal transplantation in
endemic areas; appropriate examinations should be
performed as they may help to diagnose and treat
complications in the early period, resulting in improved
prognoses.
Various chemoprophylaxis agents have been used
for a long time, but none have been completely effective
due to the drug-resistant nature of malaria. In Africa,
chloroquine resistance is widespread, and in parts of
Southeast Asia, P. falciparum is resistant to almost all
anti-malarial drugs and there are signs of the
emergence of chloroquine-resistant P. vivax [2]. The
burden of malaria is not only increased by drug
resistance but also by insecticide resistance, global
climatic changes, travel to malaria-endemic areas, and
population increase. Together with the rapid spread
of the parasites found in Southeast Asia and Africa,
these could easily herald a medical disaster. Apart
from the development of artemisinin suppositories
and combination therapy [3], there is also an urgent
need for vaccines, new drugs, and insecticides to tar-
get the Anopheles mosquito.
Erroneous diagnosis and improper treatment may
result in significant morbidity and mortality. It is thus
of the utmost importance that there is a high index of
suspicion for malaria in any patient exhibiting these
symptoms and with a history of travel to an endemic
area.
Although this report concerns cases of malaria
collected over a period of nearly 12 years, there are
still a few limitations to the study: the sample size was
small,  with only 17 cases, and the study was
retrospective, so some data, such as those on patient
history and clinical symptoms, were incomplete or
missing. Recently, a CDC website (www.cdc.gov.tw)
has been set up to facilitate the surveillance and
announcement of all infectious diseases in Taiwan. It
supplies detailed recommendations and provides a
tool for controlling epidemics, thereby preventing the
spread of malaria.
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